TNSN07370A1 - Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires - Google Patents

Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires

Info

Publication number
TNSN07370A1
TNSN07370A1 TNP2007000370A TNSN07370A TNSN07370A1 TN SN07370 A1 TNSN07370 A1 TN SN07370A1 TN P2007000370 A TNP2007000370 A TN P2007000370A TN SN07370 A TNSN07370 A TN SN07370A TN SN07370 A1 TNSN07370 A1 TN SN07370A1
Authority
TN
Tunisia
Prior art keywords
azithromycin
medicament
manufacture
treatment
ocular infections
Prior art date
Application number
TNP2007000370A
Other languages
English (en)
Inventor
Jacques Luyckx
Frederic Pilotaz
Pablo Goldschmidt
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN07370(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of TNSN07370A1 publication Critical patent/TNSN07370A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a pour objet l'utilisation de l'azithromycine pour la fabrication industrielle d'un médicament de traitement des infections oculaires, essentiellement constitué d'azithromycine en solution dans un véhicule pharmaceutiquement acceptable de triglycérides d'acides gras à chaîne linéaire de longueur moyenne à la concentration de 1 à 2 %, pour application deux fois par jour par voie topique dans chaque oeil à traiter pendant moins de quatre jours.
TNP2007000370A 2005-04-22 2007-10-01 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires TNSN07370A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
PCT/IB2006/000963 WO2006111844A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires

Publications (1)

Publication Number Publication Date
TNSN07370A1 true TNSN07370A1 (fr) 2009-03-17

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2007000370A TNSN07370A1 (fr) 2005-04-22 2007-10-01 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires

Country Status (25)

Country Link
US (2) US20060252711A1 (fr)
EP (1) EP1877066A1 (fr)
JP (1) JP2008536908A (fr)
KR (1) KR20080008377A (fr)
CN (1) CN101163486B (fr)
AR (1) AR053591A1 (fr)
AU (1) AU2006238595A1 (fr)
BR (1) BRPI0608375A2 (fr)
CA (1) CA2603833A1 (fr)
EA (1) EA200702295A1 (fr)
FR (1) FR2884716B1 (fr)
HK (1) HK1119064A1 (fr)
IL (1) IL186092A (fr)
JO (1) JO3448B1 (fr)
MA (1) MA29467B1 (fr)
MX (1) MX2007013054A (fr)
MY (1) MY169533A (fr)
NO (1) NO20075943L (fr)
PE (1) PE20070157A1 (fr)
SG (1) SG164382A1 (fr)
TN (1) TNSN07370A1 (fr)
TW (1) TWI430799B (fr)
UA (1) UA94708C2 (fr)
WO (1) WO2006111844A1 (fr)
ZA (1) ZA200709872B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (fr) 2008-03-05 2009-09-09 PARI Pharma GmbH Compositions de macrolide ayant un goût et une stabilité améliorés
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713877A (pt) * 1996-12-09 2000-03-14 Bausch & Lomb Recipiente para uso único e método para aplicar gotas de um lìquido nos olhos empregando um recipiente para uso único
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
DE69825128T3 (de) * 1997-12-02 2010-05-06 Pfizer Products Inc., Groton Verwendung von azithromycin zur topischen behandlung von augeninfektionen
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
FR2884716A1 (fr) 2006-10-27
MX2007013054A (es) 2008-01-14
KR20080008377A (ko) 2008-01-23
CN101163486A (zh) 2008-04-16
PE20070157A1 (es) 2007-03-09
IL186092A (en) 2016-05-31
UA94708C2 (ru) 2011-06-10
EA200702295A1 (ru) 2008-04-28
CA2603833A1 (fr) 2006-10-26
AU2006238595A1 (en) 2006-10-26
BRPI0608375A2 (pt) 2010-08-31
WO2006111844A1 (fr) 2006-10-26
HK1119064A1 (en) 2009-02-27
MY169533A (en) 2019-04-22
SG164382A1 (en) 2010-09-29
EP1877066A1 (fr) 2008-01-16
AR053591A1 (es) 2007-05-09
US20100069315A1 (en) 2010-03-18
CN101163486B (zh) 2011-11-30
NO20075943L (no) 2008-01-15
FR2884716B1 (fr) 2009-08-21
MA29467B1 (fr) 2008-05-02
IL186092A0 (en) 2008-01-20
ZA200709872B (en) 2008-09-25
JO3448B1 (ar) 2020-07-05
TW200716142A (en) 2007-05-01
JP2008536908A (ja) 2008-09-11
TWI430799B (zh) 2014-03-21
US20060252711A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
DE602005024160D1 (de) Zucker und/oder zuckeralkohole zur verhinderung und/oder behandlung vaginaler infektionen
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
MA29169B1 (fr) Formulations intraveineuses d'inhibiteurs de la pde-5
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
ATE358474T1 (de) Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung
TNSN07370A1 (fr) Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
FR2883182B1 (fr) Composition de vitamines utiles dans le traitement des maladies oculaires
AR055939A1 (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso
FR2883181B1 (fr) Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
DE60307086D1 (de) Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx
EP1857445A3 (fr) 2-aminoimidazoles substitués, leur procédé de fabrication et d'utilisation comme médicament ou diagnostic et médicament les contenant
RU2007132165A (ru) Адапален для длительного лечения обыкновенных угрей
FR2898497B1 (fr) Utilisation de l'apratastat ou du (s)-n-hydroxy-4-(4-but-2- ynyloxy-benzenesulfonyl)-2,2-dimethyl-thiomorpholine-3-carbo xamide dans le traitement de pathologies inflammatoires cutanees
FR3064482B1 (fr) Composition topique de doxycycline
RU2005118247A (ru) Способ комплексного антибактериального лечения генерализованной инфекции у тяжелобольных
RU2001119659A (ru) Способ лечения воспалительных заболеваний пародонта
DE60234031D1 (de) Mittel zur behandlung allergischer augenerkrankungen
DE50207436D1 (de) Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten
Nath et al. Keratitis due to Staphylococcus aureus and Acanthamoeba species following injury
FR2875404B1 (fr) Composition pharmaceutique pour le traitement de la rosacee
FR2884420B1 (fr) Nouvelle utilisation du gluconate de lithium pour le traitement de l'hidradenite suppuree
FR2832925B1 (fr) Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
FR2918278B1 (fr) Utilisation de l'oleocanthal dans le traitement de l'inflammation cutanee.
RU2003105200A (ru) Способ лечения воспалительных заболеваний пародонта
MA28210A1 (fr) Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutanee